NCT03555539View on ClinicalTrials.gov

Study of Danicopan in Participants With Hepatic Impairment

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

September 21, 2018

Study Completion Date

September 21, 2018

Conditions
Hepatic Impairment
Interventions
DRUG

Danicopan

Oral tablet.

Trial Locations (2)

32809

Clinical Trial Site, Orlando

33136

Clinical Trial Site, Miami

Sponsors
All Listed Sponsors
collaborator

Achillion, a wholly owned subsidiary of Alexion

INDUSTRY

lead

Alexion Pharmaceuticals, Inc.

INDUSTRY